HA2-FimA DNA Vaccine Treats Experimental Periodontitis
2024

HA2-FimA DNA Vaccine Treats Experimental Periodontitis

Sample size: 52 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhang Huijie, Wang Yueyue, Wang Zhu, Fu Nanqing, Wang Xinrui, Bai Guohui

Primary Institution: Zunyi Medical University

Hypothesis

The study aims to investigate the therapeutic effect of the HA2-FimA vaccine on experimental periodontitis in rats.

Conclusion

The HA2-FimA DNA vaccine can increase the levels of SIgA and CAMP in the saliva of experimental periodontitis model rats and reduce alveolar bone loss.

Supporting Evidence

  • The HA2-FimA vaccine group showed higher levels of SIgA and CAMP compared to other groups.
  • Micro-CT results indicated significantly less alveolar bone loss in the vaccine group.
  • RNA sequencing identified six key genes related to immune response.

Takeaway

Scientists tested a new vaccine on rats to see if it could help with gum disease, and it worked by boosting their immune response and protecting their teeth.

Methodology

The study involved immunizing rats with the HA2-FimA vaccine and measuring immune responses and alveolar bone loss using RNA sequencing and micro-CT.

Limitations

The study did not include inflammation markers associated with periodontal disease.

Participant Demographics

Male Sprague Dawley rats, aged 4 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3290/j.ohpd.b5281939

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication